Skip to main content
Caplight Logo









Ora Biomedical, Inc.

Ora Biomedical, Inc.

Private
Tukwila, WashingtonHealthcare & Life Scienceshttps://orabiomedical.com/

Last Round

Grant

Sep 2, 2024

Est. Valuation

$15M

Total Funding Raised

$2.29M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Ora Biomedical, Inc. is a biotechnology company that uses a proprietary robotics and AI platform for high-throughput drug screening in live animals to discover and develop therapeutics for longevity and age-related diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts, Revenue Share

AI Layer

Application

Keywords

longevity researchdrug discoveryhigh-throughput screeninghealthspangeroprotectionC. elegansautomated screeningbiotech contract researchphenotypic analysisanti-aging researchlongevity biotechCROcontract research organizationAI drug discoverylab automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ora Biomedical, Inc. Comparables

Compare Ora Biomedical, Inc. with similar companies based on industry and business-model similarity.

Ora Biomedical, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Magnitude Biosciences
87%
vivoVerse
85%
NemaLife
84%

Ora Biomedical, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 2, 2024
GrantMay 24, 2024
SeedJan 26, 2024
SeedOct 1, 2023
Pre SeedAug 29, 2022

Key People

Founding team and executive leadership

Ben Blue

Chief Executive Officer

Executive Team

Ora Biomedical, Inc. Investors

Notable investors and investment history

Ora Biomedical, Inc. investors
InvestorRounds
NIH RADxGrant
VitaDAOSeed
United States Department of the Air ForceGrant
Sand Hill AngelsPre Seed
AFVenturesGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors increased 71% MoM, reaching 1.6K.

  • Jun 1, 2026

    Grew 38% QoQ from 8 to 11 employees.

Ora Biomedical, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ora Biomedical, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ora Biomedical, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersTukwila, Washington
Employee Range11
Year Founded2022
Last FundingSep 2, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?